Product image of Ipigrix (Ipidacrine Hydrochloride) supplied by GNH India

Ipigrix

Active Ingredient:
Ipidacrine Hydrochloride
Origin:
EU

Ipigrix (Ipidacrine Hydrochloride)

Ipidacrine Hydrochloride, the active ingredient in Ipigrix, is an acetylcholinesterase inhibitor presented as an injectable solution for intramuscular or subcutaneous use. It is employed to raise acetylcholine levels in conditions where cholinergic activity is deficient, such as certain neuromuscular and cognitive disorders.

GNH India supplies Ipigrix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Manufacturer / TM Owner

Grindeks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ipigrix is an acetylcholinesterase inhibitor that acts on cholinergic pathways to improve neuromuscular transmission and cognitive function.

  • Myasthenia gravis: enhances muscle strength by increasing synaptic acetylcholine.
  • Post‑stroke cognitive impairment: supports memory and attention by augmenting cholinergic signaling.
  • Certain neuromuscular disorders: improves neuromuscular junction efficiency in selected patients.

How It Works

  • Ipidacrine Hydrochloride reversibly binds to the active site of acetylcholinesterase, preventing the enzymatic breakdown of acetylcholine in the synaptic cleft. This inhibition leads to elevated concentrations of acetylcholine, thereby enhancing cholinergic neurotransmission at both central and peripheral synapses, which can improve muscle contraction and cognitive processes.

Side Effects

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: increased bowel movements.
  • Abdominal cramps: discomfort in the stomach area.
  • Increased salivation: excess oral secretions.
  • Sweating: heightened perspiration.
  • Muscle cramps: involuntary muscle tightening.

Serious or Rare Side Effects

  • Cholinergic crisis: severe muscle weakness and respiratory difficulty.
  • Bradycardia: markedly slow heart rate.
  • Bronchospasm: narrowing of airways causing breathing trouble.
  • Seizures: uncontrolled electrical activity in the brain.
  • Anaphylaxis: life‑threatening allergic reaction.
  • Hepatotoxicity: liver enzyme elevations indicating possible liver injury.

Precautions & Warnings

Before initiating therapy, consider the following precautions:

  • Cardiac monitoring: patients with pre‑existing heart block or bradyarrhythmias should be observed.
  • Respiratory status: avoid use in individuals with severe asthma or chronic obstructive pulmonary disease.
  • Renal function: dose adjustment may be required in renal impairment.
  • Concomitant anticholinergics: may diminish therapeutic effect.
  • Pregnancy and lactation: use only if the potential benefit justifies the potential risk.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Major Interactions (Avoid)

  • Other cholinesterase inhibitors: additive cholinergic effects may precipitate crisis.
  • Anticholinergic agents: antagonize the drug’s action, reducing efficacy.
  • Beta‑blockers: may exacerbate bradycardia.

Moderate Interactions (Monitor Closely)

  • Sedatives and hypnotics: may increase risk of respiratory depression.
  • Diuretics: potential electrolyte disturbances.
  • Antihypertensives: possible additive hypotensive effect.

Frequently Asked Questions

Ipigrix contains Ipidacrine Hydrochloride, an acetylcholinesterase inhibitor used to increase acetylcholine levels in conditions such as myasthenia gravis, post‑stroke cognitive impairment, and selected neuromuscular disorders where enhanced cholinergic transmission is beneficial.

Ipidacrine Hydrochloride reversibly inhibits the enzyme acetylcholinesterase, which normally degrades acetylcholine. By blocking this enzyme, the drug raises acetylcholine concentrations at synapses, improving nerve‑muscle communication and supporting cognitive processes.

The dosage of Ipigrix is determined by the prescribing clinician based on the patient’s condition, age, weight, and response to therapy. Only a qualified healthcare professional should set the appropriate dose and administration schedule.

Safety data for Ipigrix in pregnancy and lactation are limited. It should be used only if the potential therapeutic benefit outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Ipigrix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Ipigrix (Ipidacrine) is a reversible inhibitor similar to other agents like neostigmine or pyridostigmine, but it may have a longer duration of action and a distinct side‑effect profile. Choice of agent depends on the specific clinical scenario, patient tolerance, and physician preference.

Ipigrix should be stored below 25 °C, in its original packaging, and protected from moisture. Maintaining these conditions helps preserve the drug’s stability and potency throughout its shelf life.

Ipigrix is supplied as an injectable solution for intramuscular or subcutaneous injection. Administration is performed by a qualified healthcare professional following aseptic technique and the dosing instructions provided by the prescriber.

Serious risks include cholinergic crisis, severe bradycardia, bronchospasm, seizures, and rare allergic reactions such as anaphylaxis. Patients should be monitored closely for these events, especially during dose initiation or escalation.

Ipigrix is contraindicated in patients with known hypersensitivity to Ipidacrine or any formulation components, those with severe cardiac conduction disorders, uncontrolled asthma, or in individuals taking conflicting anticholinergic medications without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ipidacrine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT